Press Releases

Intro text. Docendi indoctum mel et, sed explicari moderatius cu. Quo rebum laudem dissentiunt cu. Per assum noster urbanitas ex, eum cu iracundia hendrerit vulome prostagma.

Our paper has been published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. Mario A Parra MD PhD, Juan Granada MD, gerardo fernandez PhD, et al. (2022). In a 40-month prospective study, ViewMind showed:

Created by Gerardo Fernandez

Highlights: • A biomarker to 'prospectively' predict Alzheimer's Disease with high accuracy. PPV 94% and NPV 100% • Ability to very accurately differentiate cognitive decline…

Memory-driven eye movements prospectively predict dementia in people at risk of Alzheimer’s disease

Created by ViewMind

Oculomotor behaviors linked to cognitive performance revealed neurocognitive features of Alzheimer’s disease (AD) that can enhance the accuracy of its assessment and diagnosis

Neurocognitive disease management leader, ViewMind Inc., announces the opening of ViewMind Labs.

Created by ViewMind

ViewMind is excited to announce the opening of ViewMind Labs at one of the most highly regarded centers of excellence globally for research and clinical…

ViewMind Inc. announces the appointment of Denise Kelly as Vice President Sales & Business Development

Created by Mark Edwards

ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders

Created by Mark Edwards

ViewMind Applauded by Frost & Sullivan for Its One-of-a-kind Digital Biomarker Technology for Neurocognitive Disorders

Created by ViewMind

ViewMind: Most Innovative Digital Health A.I. Company - Europe & Leading Experts in Neurocognitive Digital Biomarkers

Created by ViewMind

ViewMind Inc. Announces Appointment of Chief Executive Officer

Created by Mark Edwards